Nystatin, Neomycin Sulfate, Thiostrepton And Triamcinolone Acetonide

22 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

910.0%

Death Rate

Active Ingredients

Nystatin, Neomycin Sulfate, Thiostrepton And Triamcinolone Acetonide

Administration Routes

TopicalAuricular (Otic)Unknown

Species Affected

Dog 16

Cat 6

Most Affected Breeds

Domestic Shorthair 3

Retriever - Labrador 2

Bulldog 2

Poodle - Toy 1

Dachshund (unspecified) 1

Terrier - Bull - American Pit 1

Chihuahua 1

Boxer (German Boxer) 1

Spaniel - Springer English 1

Dog (unknown) 1

Most Reported Reactions

Decreased appetite 2

Vomiting 2

Application site infection 2

Underdose 2

Lethargy (see also Central nervous system depression in 'Neurological') 2

Decreased packed cell volume (PCV) 2

Emesis 1

Salivary gland disorder 1

Walking difficulty 1

Muscle spasm NOS 1

Moist dermatitis 1

Dermal mass 1

Outcome Breakdown

Ongoing

9 (40.9%)

Outcome Unknown

8 (36.4%)

Recovered/Normal

3 (13.6%)

Died

2 (9.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.